These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24556685)

  • 1. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
    Buckley NE; D'Costa Z; Kaminska M; Mullan PB
    Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+/S100 proteins act as upstream regulators of the chaperone-associated ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein).
    Shimamoto S; Kubota Y; Yamaguchi F; Tokumitsu H; Kobayashi R
    J Biol Chem; 2013 Mar; 288(10):7158-68. PubMed ID: 23344957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway.
    Hibi K; Fujitake S; Takase T; Kodera Y; Ito K; Akiyama S; Shirane M; Nakao A
    Clin Cancer Res; 2003 Sep; 9(11):4282-5. PubMed ID: 14519656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.
    Buckley NE; Conlon SJ; Jirstrom K; Kay EW; Crawford NT; O'Grady A; Sheehan K; Mc Dade SS; Wang CW; McCance DJ; Johnston PG; Kennedy RD; Harkin DP; Mullan PB
    Cancer Res; 2011 Mar; 71(5):1933-44. PubMed ID: 21363924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.
    Kirschner RD; Sänger K; Müller GA; Engeland K
    Nucleic Acids Res; 2008 May; 36(9):2969-80. PubMed ID: 18388131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation.
    Lapi E; Iovino A; Fontemaggi G; Soliera AR; Iacovelli S; Sacchi A; Rechavi G; Givol D; Blandino G; Strano S
    Oncogene; 2006 Jun; 25(26):3628-37. PubMed ID: 16449968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of the human S100A2 promoter by wild-type p53.
    Tan M; Heizmann CW; Guan K; Schafer BW; Sun Y
    FEBS Lett; 1999 Feb; 445(2-3):265-8. PubMed ID: 10094469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.
    Mueller A; Schäfer BW; Ferrari S; Weibel M; Makek M; Höchli M; Heizmann CW
    J Biol Chem; 2005 Aug; 280(32):29186-93. PubMed ID: 15941720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53-S100A2 Positive Feedback Loop Negatively Regulates Epithelialization in Cutaneous Wound Healing.
    Pan SC; Li CY; Kuo CY; Kuo YZ; Fang WY; Huang YH; Hsieh TC; Kao HY; Kuo Y; Kang YR; Tsai WC; Tsai ST; Wu LW
    Sci Rep; 2018 Apr; 8(1):5458. PubMed ID: 29615682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
    Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
    Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion.
    Naz S; Ranganathan P; Bodapati P; Shastry AH; Mishra LN; Kondaiah P
    Biochem J; 2012 Oct; 447(1):81-91. PubMed ID: 22747445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
    Ruckova E; Muller P; Nenutil R; Vojtesek B
    Cell Mol Biol Lett; 2012 Sep; 17(3):446-58. PubMed ID: 22669480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
    Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
    Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.
    Amin R; Morita-Fujimura Y; Tawarayama H; Semba K; Chiba N; Fukumoto M; Ikawa S
    Mol Oncol; 2016 Apr; 10(4):575-93. PubMed ID: 26704768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53.
    King FW; Wawrzynow A; Höhfeld J; Zylicz M
    EMBO J; 2001 Nov; 20(22):6297-305. PubMed ID: 11707401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.
    Smith SL; Gugger M; Hoban P; Ratschiller D; Watson SG; Field JK; Betticher DC; Heighway J
    Br J Cancer; 2004 Oct; 91(8):1515-24. PubMed ID: 15467767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
    Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
    Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain.
    Shimamoto S; Takata M; Tokuda M; Oohira F; Tokumitsu H; Kobayashi R
    J Biol Chem; 2008 Oct; 283(42):28246-58. PubMed ID: 18669640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.
    Johnson N; Johnson SF; Yao W; Li YC; Choi YE; Bernhardy AJ; Wang Y; Capelletti M; Sarosiek KA; Moreau LA; Chowdhury D; Wickramanayake A; Harrell MI; Liu JF; D'Andrea AD; Miron A; Swisher EM; Shapiro GI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17041-6. PubMed ID: 24085845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.
    Yun J; Espinoza I; Pannuti A; Romero D; Martinez L; Caskey M; Stanculescu A; Bocchetta M; Rizzo P; Band V; Band H; Kim HM; Park SK; Kang KW; Avantaggiati ML; Gomez CR; Golde T; Osborne B; Miele L
    J Cell Physiol; 2015 Dec; 230(12):3115-27. PubMed ID: 26033683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.